Logo image of EBIX

EBIX INC (EBIX) Stock Fundamental Analysis

NASDAQ:EBIX - Nasdaq - US2787152063 - Common Stock - Currency: USD

1.16  -0.55 (-32.16%)

After market: 1.1603 +0 (+0.03%)

Fundamental Rating

4

EBIX gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 284 industry peers in the Software industry. There are concerns on the financial health of EBIX while its profitability can be described as average. EBIX has a bad growth rate and is valued cheaply.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year EBIX was profitable.
In the past year EBIX had a positive cash flow from operations.
In the past 5 years EBIX has always been profitable.
Each year in the past 5 years EBIX had a positive operating cash flow.
EBIX Yearly Net Income VS EBIT VS OCF VS FCFEBIX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M

1.2 Ratios

EBIX has a better Return On Assets (0.32%) than 71.94% of its industry peers.
EBIX has a better Return On Equity (0.82%) than 73.74% of its industry peers.
EBIX's Return On Invested Capital of 13.72% is amongst the best of the industry. EBIX outperforms 94.24% of its industry peers.
The Average Return On Invested Capital over the past 3 years for EBIX is in line with the industry average of 12.17%.
The 3 year average ROIC (10.38%) for EBIX is below the current ROIC(13.72%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.32%
ROE 0.82%
ROIC 13.72%
ROA(3y)4.81%
ROA(5y)5.26%
ROE(3y)11.98%
ROE(5y)14.6%
ROIC(3y)10.38%
ROIC(5y)10.3%
EBIX Yearly ROA, ROE, ROICEBIX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 5 10 15 20

1.3 Margins

EBIX has a Profit Margin of 0.68%. This is in the better half of the industry: EBIX outperforms 72.30% of its industry peers.
EBIX's Profit Margin has declined in the last couple of years.
EBIX's Operating Margin of 14.94% is amongst the best of the industry. EBIX outperforms 86.69% of its industry peers.
In the last couple of years the Operating Margin of EBIX has declined.
The Gross Margin of EBIX (47.00%) is worse than 69.06% of its industry peers.
EBIX's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 14.94%
PM (TTM) 0.68%
GM 47%
OM growth 3Y-24.69%
OM growth 5Y-18.1%
PM growth 3Y-28.25%
PM growth 5Y-25.95%
GM growth 3Y-21.49%
GM growth 5Y-13.45%
EBIX Yearly Profit, Operating, Gross MarginsEBIX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 20 40 60

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), EBIX is creating value.
The number of shares outstanding for EBIX has been increased compared to 1 year ago.
Compared to 1 year ago, EBIX has a worse debt to assets ratio.
EBIX Yearly Shares OutstandingEBIX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M
EBIX Yearly Total Debt VS Total AssetsEBIX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 500M 1B 1.5B

2.2 Solvency

Based on the Altman-Z score of 1.06, we must say that EBIX is in the distress zone and has some risk of bankruptcy.
EBIX has a worse Altman-Z score (1.06) than 61.87% of its industry peers.
The Debt to FCF ratio of EBIX is 30.67, which is on the high side as it means it would take EBIX, 30.67 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of EBIX (30.67) is comparable to the rest of the industry.
EBIX has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
EBIX has a better Debt to Equity ratio (0.03) than 61.15% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 30.67
Altman-Z 1.06
ROIC/WACC2.69
WACC5.1%
EBIX Yearly LT Debt VS Equity VS FCFEBIX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 200M 400M 600M

2.3 Liquidity

A Current Ratio of 0.41 indicates that EBIX may have some problems paying its short term obligations.
EBIX's Current ratio of 0.41 is on the low side compared to the rest of the industry. EBIX is outperformed by 95.32% of its industry peers.
EBIX has a Quick Ratio of 0.41. This is a bad value and indicates that EBIX is not financially healthy enough and could expect problems in meeting its short term obligations.
EBIX has a Quick ratio of 0.41. This is amonst the worse of the industry: EBIX underperforms 95.32% of its industry peers.
Industry RankSector Rank
Current Ratio 0.41
Quick Ratio 0.41
EBIX Yearly Current Assets VS Current LiabilitesEBIX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 200M 400M 600M 800M

2

3. Growth

3.1 Past

EBIX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -92.74%.
Measured over the past years, EBIX shows a decrease in Earnings Per Share. The EPS has been decreasing by -7.91% on average per year.
EBIX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -30.72%.
The Revenue has been growing by 23.60% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-92.74%
EPS 3Y-14.5%
EPS 5Y-7.91%
EPS Q2Q%-155.93%
Revenue 1Y (TTM)-30.72%
Revenue growth 3Y21.84%
Revenue growth 5Y23.6%
Sales Q2Q%-53.78%

3.2 Future

Based on estimates for the next years, EBIX will show a very negative growth in Earnings Per Share. The EPS will decrease by -17.98% on average per year.
Based on estimates for the next years, EBIX will show a very negative growth in Revenue. The Revenue will decrease by -31.80% on average per year.
EPS Next Y-87.37%
EPS Next 2Y-17.98%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-42.79%
Revenue Next 2Y-31.8%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
EBIX Yearly Revenue VS EstimatesEBIX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
EBIX Yearly EPS VS EstimatesEBIX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1 2 3

8

4. Valuation

4.1 Price/Earnings Ratio

EBIX is valuated cheaply with a Price/Earnings ratio of 6.82.
Compared to the rest of the industry, the Price/Earnings ratio of EBIX indicates a rather cheap valuation: EBIX is cheaper than 96.76% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 24.21, EBIX is valued rather cheaply.
A Price/Forward Earnings ratio of 0.82 indicates a rather cheap valuation of EBIX.
EBIX's Price/Forward Earnings ratio is rather cheap when compared to the industry. EBIX is cheaper than 100.00% of the companies in the same industry.
EBIX's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 20.44.
Industry RankSector Rank
PE 6.82
Fwd PE 0.82
EBIX Price Earnings VS Forward Price EarningsEBIX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, EBIX is valued cheaper than 97.84% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, EBIX is valued cheaply inside the industry as 99.64% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 1.74
EV/EBITDA 4.14
EBIX Per share dataEBIX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

The decent profitability rating of EBIX may justify a higher PE ratio.
EBIX's earnings are expected to decrease with -17.98% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-17.98%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for EBIX!.
Industry RankSector Rank
Dividend Yield N/A

EBIX INC

NASDAQ:EBIX (12/27/2023, 8:25:48 PM)

After market: 1.1603 +0 (+0.03%)

1.16

-0.55 (-32.16%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-14 2023-11-14/bmo
Earnings (Next)03-13 2024-03-13/amc
Inst Owners0.52%
Inst Owner Change0%
Ins Owners25.36%
Ins Owner Change0%
Market Cap35.84M
Analysts85.71
Price Target15.05 (1197.41%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.3
Dividend Growth(5Y)0.25%
DP46%
Div Incr Years0
Div Non Decr Years9
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-313.68%
Min EPS beat(2)-531.37%
Max EPS beat(2)-96%
EPS beat(4)0
Avg EPS beat(4)-178.32%
Min EPS beat(4)-531.37%
Max EPS beat(4)-32.69%
EPS beat(8)2
Avg EPS beat(8)-91.14%
EPS beat(12)3
Avg EPS beat(12)-65.24%
EPS beat(16)4
Avg EPS beat(16)-45.59%
Revenue beat(2)0
Avg Revenue beat(2)-15.05%
Min Revenue beat(2)-24.13%
Max Revenue beat(2)-5.97%
Revenue beat(4)0
Avg Revenue beat(4)-8.43%
Min Revenue beat(4)-24.13%
Max Revenue beat(4)-0.34%
Revenue beat(8)3
Avg Revenue beat(8)5.53%
Revenue beat(12)6
Avg Revenue beat(12)7.6%
Revenue beat(16)7
Avg Revenue beat(16)6.13%
PT rev (1m)0%
PT rev (3m)-33.71%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-50%
EPS NY rev (1m)0%
EPS NY rev (3m)-45.26%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-8.76%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.67%
Valuation
Industry RankSector Rank
PE 6.82
Fwd PE 0.82
P/S 0.05
P/FCF 1.74
P/OCF 1
P/B 0.06
P/tB N/A
EV/EBITDA 4.14
EPS(TTM)0.17
EY14.66%
EPS(NY)1.41
Fwd EY121.78%
FCF(TTM)0.67
FCFY57.47%
OCF(TTM)1.16
OCFY100.16%
SpS23.81
BVpS19.78
TBVpS-11.2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.32%
ROE 0.82%
ROCE 15.78%
ROIC 13.72%
ROICexc 15.67%
ROICexgc N/A
OM 14.94%
PM (TTM) 0.68%
GM 47%
FCFM 2.8%
ROA(3y)4.81%
ROA(5y)5.26%
ROE(3y)11.98%
ROE(5y)14.6%
ROIC(3y)10.38%
ROIC(5y)10.3%
ROICexc(3y)12%
ROICexc(5y)11.71%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)11.77%
ROCE(5y)11.72%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y20.04%
ROICexc growth 5Y10.36%
OM growth 3Y-24.69%
OM growth 5Y-18.1%
PM growth 3Y-28.25%
PM growth 5Y-25.95%
GM growth 3Y-21.49%
GM growth 5Y-13.45%
F-Score5
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 30.67
Debt/EBITDA 0.12
Cap/Depr 70.18%
Cap/Sales 2.08%
Interest Coverage 1.86
Cash Conversion 27.26%
Profit Quality 412%
Current Ratio 0.41
Quick Ratio 0.41
Altman-Z 1.06
F-Score5
WACC5.1%
ROIC/WACC2.69
Cap/Depr(3y)75.83%
Cap/Depr(5y)84.35%
Cap/Sales(3y)1.64%
Cap/Sales(5y)2.07%
Profit Quality(3y)89.22%
Profit Quality(5y)78.73%
High Growth Momentum
Growth
EPS 1Y (TTM)-92.74%
EPS 3Y-14.5%
EPS 5Y-7.91%
EPS Q2Q%-155.93%
EPS Next Y-87.37%
EPS Next 2Y-17.98%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-30.72%
Revenue growth 3Y21.84%
Revenue growth 5Y23.6%
Sales Q2Q%-53.78%
Revenue Next Year-42.79%
Revenue Next 2Y-31.8%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-10.65%
EBIT growth 3Y-8.24%
EBIT growth 5Y1.22%
EBIT Next Year21.62%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-62.55%
FCF growth 3Y5.41%
FCF growth 5Y-3.37%
OCF growth 1Y-47.51%
OCF growth 3Y8.47%
OCF growth 5Y0.21%